Is there a chance for cancer research fields, such as exponential growth of infected blood cells methodology, to be related to COVID-19 research generally?
This is an interesting question. i think it depends on the type of cancer here. Perhaps certain biomarkers can serve as a good indication?
This is an interesting question. i think it depends on the type of cancer here. Perhaps certain biomarkers can serve as a good indication?
Very interesting article
Article The Impact of COVID-19 on Cancer Risk and Treatment
Its a very good discussion, multidimensional. Despite of its relation and co-morbidity etc one very depressing moment is for thalassemic patients, as they need blood while people refuse to donate blood these days, people think of COVID and immunity sort of thing and refuse to donate.
Hi,
Mortality from COVID-19 in cancer patients appears to be principally driven by age, gender, and comorbidities.
Here"s an article that addresses this issue.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31173-9/fulltext
Cancer and COVID-19 both are more dangerous .The cancer weakens immune systems where as COVID-19 causes problems of cough, fever and breathing.
Light COVID-19 can limit early cancer activity, temporary only, as it happens after repairable injuring of the strong lymphopoiesis by any moderate cytotoxic agent, including conventional anticancer drugs and radiation. In the case of strong COVID-19 and advanced cancer, the final result will be undoubtfully poor due to complete lymphopoiesis exhaustion. That is because of the lymphopoietic activity, cancer, and body tissue renewal both relate directly.
- Badges
- Science topic
- Similar topics
- Medicine
- Oncology
- Cancer Research